Laurus Synthesis Private Limited

Laurus Synthesis Private Limited - pharma in Anakapalle, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U24110AP2020PTC121364 Incorporated 18 May 2020 ROC Vijayawada HQ Anakapalle, Andhra Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2026
₹497.61 Cr
▲ 108% YoY
Net profit · FY 2026
₹76.54 Cr
Net margin 15.4%
EBITDA · FY 2026
₹244.71 Cr
EBITDA margin 49.2%
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹10.76 Lakh
Issued & subscribed
Open charges
₹371.22 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
211
Provident fund records

About Laurus Synthesis Private Limited

Data last updated:

Laurus Synthesis Private Limited is a private limited company based in Anakapalle, Andhra Pradesh, India, a subsidiary of Laurus Labs Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 May 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24110AP2020PTC121364. Its GSTIN is 37AAECL2090C1ZS (Andhra Pradesh). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹10.76 Lakh. It is led by directors including Sita Ramaiah Chagarlamudi and Venkata Lakshmi Narasimha Rao Dammalapati.

Its last annual general meeting (AGM) was held on 12 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Anakapalle, Andhra Pradesh.

As per the financials filed for FY 2026, the company reported a revenue of ₹497.61 Cr, a growth of 108% compared to the previous year. For the same year it recorded a net profit of ₹76.54 Cr (net margin 15.4%) and EBITDA of ₹244.71 Cr (EBITDA margin 49.2%). Revenue has grown at a compounded annual rate (CAGR) of 66% over three years and 100% over five years.

The company has about 211 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Laurus Synthesis and Laurus Labs. As per MCA filings, the company has open charges of ₹371.22 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.

For more details, the company can be reached via its website laurussynthesis.com.

Company details

CIN U24110AP2020PTC121364
Registration Number 121364
Incorporation Date 18 May 2020
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 12 June 2025
Date of Balance Sheet 31 March 2025
Parent Company Laurus Labs Limited

CIN history

Laurus Synthesis has one previous CIN (Corporate Identification Number): U24110TG2020PTC140333. The current CIN is U24110AP2020PTC121364, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24110AP2020PTC121364Current
U24110TG2020PTC140333Previous

Contact details

Laurus Synthesis Private Limited's registered office is in Anakapalle, Andhra Pradesh.

  • Social Media
  • Registered Address
    01st Floor Laurus Enclave Plot Office 01, Edulapaka Bonangi Village Parawada Mandal Anakapalli District, Anakapalle, Andhra Pradesh, India – 531021
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Laurus Synthesis Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Laurus Synthesis operates two associated brands: Laurus Synthesis and Laurus Labs. Each brand links to its own profile.

BrandDescriptionWebsite
Offers CDMO services for APIs, intermediates, and key starting materials.laurussynthesis.com
Pharmaceutical and biotechnology companylauruslabs.com

Business activity

The main business activity of Laurus Synthesis is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Laurus Synthesis Private Limited, buy the company report.

Financials of Laurus Synthesis Private Limited

FY 2025 filings available

Laurus Synthesis Private Limited reported revenue of ₹497.61 Cr (up 108% YoY) for FY 2026.

Revenue · FY 2026
₹497.61 Cr ▲ 108%
Net profit · FY 2026
₹76.54 Cr margin 15.4%
EBITDA · FY 2026
₹244.71 Cr margin 49.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 108%
3 years · compounded
▲ 66%
5 years · compounded
▲ 100%
EBITDA CAGR growth
1 year
▲ 119%
3 years · compounded
▲ 65%
5 years · compounded
▲ 103%

Revenue has grown at a compounded annual rate (CAGR) of 100% over five years, including 108% growth in the latest year. EBITDA rose 119% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹244.71 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹76.54 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin49.2%
Net Profit Margin15.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Laurus Synthesis Private Limited, buy the company report.

Board of directors of Laurus Synthesis Private Limited

Laurus Synthesis has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sita Ramaiah ChagarlamudiDirector18 May 20206 Years 5 MonthsCurrent
Venkata Lakshmi Narasimha Rao DammalapatiDirector23 Jul 20206 Years 3 MonthsCurrent
Soumya ChavaDirector22 Jul 20215 Years 3 MonthsCurrent
Narasimha Rao ChavaDirector17 Aug 20206 Years 2 MonthsCurrent
Krishna Chaitanya ChavaDirector18 May 20206 Years 5 MonthsCurrent

Peer comparison

Laurus Synthesis Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Laurus Synthesis Private Limitedthis company₹497.61 Cr (FY 2026)₹76.54 Cr15.4%108.0%Anakapalle, Andhra Pradesh, India
Khandelwal Laboratories Private Limited₹240.41 Cr (FY 2025)2.0%Mumbai, Maharashtra, India
Ideal Cures Private Limited₹239.81 Cr (FY 2025)6.0%Mumbai, Maharashtra, India
Healthcaps India Limited₹239.43 Cr (FY 2025)-2.0%Fatehpur, Punjab, India
Kemwell Biopharma Private Limited₹239.14 Cr (FY 2025)10.0%Bangalore, Karnataka, India
Stallion Laboratories Pvt Ltd₹234.32 Cr (FY 2024)25.0%Ahmedabad, Gujarat, India
Emil Pharmaceutical Industries Private Limited₹232.55 Cr (FY 2025)10.0%Mumbai, Maharashtra, India

To see the full peer comparison of Laurus Synthesis Private Limited, buy the company report.

Charges & borrowings

Open charges
₹371.22 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹211.22 Cr
Hdfc Bank Limited₹155.00 Cr
Others₹5.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Oct 2023100812500Hdfc Bank Limited₹155 CrOpen
04 Aug 2022100623956State Bank of India₹211.22 CrOpen
24 Mar 2021100437596Others₹5 CrOpen

To see the full charge records of Laurus Synthesis Private Limited, buy the company report.

Total charge records: 3 View all charges

Credit ratings & regulatory alerts

Laurus Synthesis Private Limited was last rated by Care on 04 Aug 2022.

Rating agencyRated onRating
Care04 Aug 2022

To see the full credit ratings and regulatory alerts of Laurus Synthesis Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Laurus Synthesis Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Laurus Synthesis has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
37AAECL2090C1ZSAndhra PradeshActive01 Jun 2020
36AAECL2090C1ZUTelanganaActive30 Oct 2020

To see the full GST registrations and return filing status of Laurus Synthesis Private Limited, buy the company report.

Recent activity

Laurus Synthesis Private Limited has 8 board changes on record since 2020: 5 appointments and 3 cessations. The latest: Soumya Chava ceased to be Additional Director on 27 Jun 2022.

AGM
Laurus Synthesis Private Limited last Annual general meeting of members was held on 12 Jun 2025 as per latest MCA records.
Filing
Laurus Synthesis Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Charges
A charge with Others of Rs. 5.00 Cr registered on 24 Mar 2021 with Charge ID 100437596 was modified on 23 Dec 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 155.00 Cr registered on 24 Oct 2023 with Charge ID 100812500 was modified on 23 Sep 2024.
Charges
A charge with State Bank Of India of Rs. 211.22 Cr registered on 04 Aug 2022 with Charge ID 100623956 was modified on 23 Sep 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 155.00 Cr with Charge ID 100812500 was registered on 24 Oct 2023.
Charges
A charge with State Bank Of India amounted to Rs. 211.22 Cr with Charge ID 100623956 was registered on 04 Aug 2022.
Ceased
Soumya Chava ceased to be Additional Director.
Appointed
Soumya Chava was appointed as Director.
Ceased
Narasimha Rao Chava ceased to be Additional Director.
Ceased
Venkata Lakshmi Narasimha Rao Dammalapati ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100437596 was registered on 24 Mar 2021.

5 earlier events are in the company report.

Frequently asked questions

Laurus Synthesis is an active private limited company based in Anakapalle, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 May 2020 (6+ years old) and is registered under CIN U24110AP2020PTC121364.

Laurus Synthesis has 5 current directors:

The latest financial statements of Laurus Synthesis on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 12 June 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Laurus Synthesis is 37AAECL2090C1ZS, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAECL2090C1ZU (Telangana).

The CIN (Corporate Identification Number) of Laurus Synthesis is U24110AP2020PTC121364. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Laurus Synthesis has 1 court case on record: 1 filed by the company.

Laurus Synthesis was incorporated on 18 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Vijayawada.

The peers of Laurus Synthesis by revenue are Khandelwal Laboratories Private Limited, Ideal Cures Private Limited, Healthcaps India Limited, Kemwell Biopharma Private Limited, Stallion Laboratories Pvt Ltd and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Soumya Chava ceased to be Additional Director on 27 Jun 2022. Soumya Chava was appointed as Director on 22 Jul 2021. Narasimha Rao Chava ceased to be Additional Director on 24 Jun 2021. Laurus Synthesis has 8 board changes on record in total.

Laurus Synthesis can be reached through the website laurussynthesis.com. Its registered office is in Anakapalle, Andhra Pradesh, India.

The registered office of Laurus Synthesis is at 01st Floor Laurus Enclave Plot Office 01, Edulapaka Bonangi Village Parawada Mandal Anakapalli District, Anakapalle, Andhra Pradesh, India – 531021.